Intra-Omicron Reinfection with JN.1.16 and NB.1.8.1 in a Preterm Infant: First NB.1.8.1 Detection in Tunisia—A Case Report
Authors:
- Zaineb HamzaouiZHZaineb Hamzaoui
- Sana FerjaniSFSana Ferjani
- Ameni SallemiASAmeni Sallemi
- Salma AbidSASalma Abid
- Amal MiraouiAMAmal Miraoui
- Ichrak LandolsiILIchrak Landolsi
- Latifa CharaaLCLatifa Charaa
- Khaled MenifKMKhaled Menif
- Lamia KanzariLKLamia Kanzari
- Ilhem Boutiba-Ben BoubakerIBIlhem Boutiba-Ben Boubaker
Open Access
- 30 April 2026
- journal article
- case report
- Published by MDPI AG in Microorganisms
- Vol. 14 (5) , 1009
Abstract
Highly mutated Omicron sub-lineages JN.1 and NB.1.8.1 harbor extensive spike changes, but their impact in preterm infants is poorly documented. We report a preterm male infant with three hospitalizations in seven weeks: severe SARS-CoV-2 ARDS at 40 days of life (DOL 40) requiring ventilation caused by JN.1.16, HCoV-OC43 infection at DOL 65, and a mild SARS-CoV-2 reinfection at DOL 87 due to NB.1.8.1, the first detection of this variant in Tunisia. Spike analysis showed a shared JN.1 backbone but distinct N-terminal and receptor-binding domain changes, supporting intra-Omicron reinfection driven by antigenic divergence and immature immunity and underscoring the value of pediatric genomic surveillance, including phylogenetic placement of case genomes within local Omicron diversity.Keywords
Funding Information
- Ministry of Higher Education and Scientific Research of Tunisia
This publication has 21 references indexed in Scilit:
- Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariantsCell Reports, 2025
- Virological characteristics of the SARS-CoV-2 NB.1.8.1 variantThe Lancet Infectious Diseases, 2025
- Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1The Lancet Infectious Diseases, 2025
- Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3Nature Communications, 2024
- A mini review of reinfection with the SARS‐CoV‐2 Omicron variantHealth Science Reports, 2024
- Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionNature Communications, 2024
- Bacterial coinfection in young febrile infants with SARS-CoV-2 infectionEuropean Journal of Pediatrics, 2023
- Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineageNature Communications, 2022
- “Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants”Journal of Infection, 2022
- Synthesis and systematic review of reported neonatal SARS-CoV-2 infectionsNature Communications, 2020